T cell engager (TCE) score in patients treated with bispecific CD3 TCE in phase I clinical trials. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback